Literature DB >> 24818116

NK cell therapy for end-stage cancerous patient: A case study.

Junichi Masuyama1, Kamon Chaiyasit2, Wanviput Sanphasitvong2, Viroj Wiwanitkit3.   

Abstract

Entities:  

Year:  2014        PMID： 24818116      PMCID： PMC4014651          DOI： 10.4103/2278-330X.130480

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN： 2278-330X


× No keyword cloud information.
  5 in total

Review 1.  The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer.

Authors:  J R Yannelli
Journal:  J Immunol Methods       Date:  1991-05-17       Impact factor: 2.303

Review 2.  Cell therapy: achievements and perspectives.

Authors:  C Bordignon; C Carlo-Stella; M P Colombo; A De Vincentiis; L Lanata; R M Lemoli; F Locatelli; A Olivieri; D Rondelli; P Zanon; S Tura
Journal:  Haematologica       Date:  1999-12       Impact factor: 9.941

Review 3.  Natural killer cell biology: an update and future directions.

Authors:  Kerry S Campbell; Jun Hasegawa
Journal:  J Allergy Clin Immunol       Date:  2013-07-30       Impact factor: 10.793

Review 4.  Advantages and clinical applications of natural killer cells in cancer immunotherapy.

Authors:  Erik Ames; William J Murphy
Journal:  Cancer Immunol Immunother       Date:  2013-08-30       Impact factor: 6.968

5.  Cancer cell cycle and adoptive immunotherapy using lymphokine-activated killer cells.

Authors:  Y Ejiri; M Ohara; T Suzuki; R Kasukawa
Journal:  Fukushima J Med Sci       Date:  1997-12
  5 in total
  1 in total

Review 1.  Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.

Authors:  Dong-Rui Wang; Xian-Lin Wu; Ying-Li Sun
Journal:  Signal Transduct Target Ther       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.